scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $158 | $241 | $203 | $137 |
| - Cash | $76 | $47 | $71 | $74 |
| + Debt | $53 | $40 | $37 | $18 |
| Enterprise Value | $135 | $235 | $170 | $81 |
| Revenue | $36 | $14 | $0 | $0 |
| % Growth | 167.3% | – | – | – |
| Gross Profit | $25 | $10 | -$0 | -$0 |
| % Margin | 68.7% | 72% | – | – |
| EBITDA | -$77 | -$46 | -$33 | -$25 |
| % Margin | -213.1% | -338.9% | – | – |
| Net Income | -$85 | -$55 | -$37 | -$28 |
| % Margin | -234.4% | -403.2% | – | – |
| EPS Diluted | -1.91 | -1.42 | -1.3 | -1.02 |
| % Growth | -34.5% | -9.2% | -27.5% | – |
| Operating Cash Flow | -$71 | -$59 | -$35 | -$27 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$71 | -$59 | -$35 | -$27 |